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Vascular changes on fluorescein 
angiography of premature infants with low risk 
of retinopathy of prematurity after high oxygen 
exposure
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Abstract 
Purpose: To describe a wide array of peripheral vascular changes using fluorescein angiography in preterm neo‑
nates, without high risk characteristics for developing retinopathy of prematurity, that were exposed to high oxygen 
concentration.
Methods: Retrospective, two center, case series. Newborns at two different hospitals with ≥1500 g or gestational 
age of ≥32 weeks, fluorescein angiography performed, and with high oxygen exposure without adequate control 
were included.
Results: 294 infants diagnosed with ROP were analyzed. Only 28 eyes from 14 patients with peripheral vascular 
abnormalities in older and heavier babies were included. Two distinct type of peripheral vascular changes were 
observed: group 1 or non‑proliferative: areas of capillary non‑perfusion along with widespread arteriovenous shunt‑
ing between adjacent primary vessels, tortuosity of primary vessels, abnormal budding of tertiary vessels and capillar‑
ies, abnormal capillary tufts and absence of foveal avascular zone; group 2 or proliferative: all of the characteristics of 
group 1 plus leakage of dye from the boundary between perfused and non‑perfused retina and/or optic disc.
Conclusion: Peripheral vascular abnormalities different from retinopathy of prematurity are observed in older than 
32 weeks of gestational age, and heavier than 1500 g babies. This makes the authors classify these patients as having 
a disease caused solely by oxygen dysregulation at the neonatal intensive care unit similarly to the oxygen induced 
retinopathy in experimental studies.
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Background
Retinopathy of prematurity (ROP) is a well-known com-
plication of preterm births, which currently represent 
about 10% of all births worldwide [1–3]. It remains as 
one of the leading causes of child blindness and visual 
disability despite aggressive governmental surveillance 
programs and educational campaigns [4].
In addition to a very-low birth weight (<1500 g) and a 
very-low gestational age (<24  weeks); deficient oxygen 
regulation (fraction of inspired oxygen) is a powerful pre-
dictor factor for ROP and neonatal survival [5]. Despite 
advances in ROP treatment in centers with sufficient 
technology for ROP screening and excellent neonatal 
care, there is still lack of consensus regarding the oxygen 
level that could avoid retinal disease and still be consid-
ered safe for the neonate [6]. According to Chen et al. the 
need of oxygen varies at different developmental stages 
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and phases of ROP: the use of low oxygen saturation (70–
96%) during the first postnatal weeks and high oxygen 
saturation (94–99%) at postmenstrual ages of 32 weeks or 
older, were both associated with decreased risk for pro-
gression to severe stages of ROP [7].
Due to recent advances in neonatal intensive care and 
successful government screening programs, the inci-
dence of the more advanced stages of ROP (stages 4 and 
5) has been decreasing in developed countries over the 
past years [8].
The increasing body of peer-review evidence suggest 
that in low and middle-income countries, the neonatal 
care and ROP screening criteria are more variable. There 
is a tendency of severe ROP appearance in older and 
heavier babies (>32 gestational age [GA] and/or >1251 g 
of birth weight [BW] in moderated-poor developed 
countries [8–10]. Therefore, more mature babies may 
suffer from ROP stages, not typically found in these age 
groups, and must be examined despite being outside of 
the recommended guidelines for screening (birth weight 
≤1500 g or gestational age of 30 weeks or less; newborns 
with a birth weight between 1500 and 2000  g or gesta-
tional age higher than 30 weeks, but under cardiorespi-
ratory support or at risk for ROP; but still had record of 
have been exposed to high concentration of oxygen for 
long periods of time during neonatal care) [9, 10]. More-
over previously vascularized retinas may suffer regres-
sion and later reactivation of the disease, which force the 
retina specialist to implement longer surveillance periods 
and properly discriminate between normal and abnormal 
peripheral vascular changes on allegedly low risk ROP 
neonates [4].
In the following study, we will describe a wide array of 
peripheral vascular changes using fluorescein angiogra-
phy in preterm neonates without high risk characteris-
tics for ROP (more than 32 weeks of postmenstrual age 
and/or more than 1251 g birth weight) but with clinical 
history of have been exposed to high concentration of 
oxygen or have not been correctly monitored during neo-
natal care. All neonates developed clinical characteristics 
similar to ROP but with remarkably different patterns on 
fluorescein angiography (FA) and natural history than 
those already described. The vascular changes described 
herein also shares similarities with another clinical entity 
described in murine models of ROP known as oxygen-
induced retinopathy (OIR) [11].
Methods
Retrospective, two center, case series. The study was 
approved by the internal review boards of the “Aso-
ciación para Evitar la Ceguera en Mexico, IAP” and the 
Neonatal Intensive Care Unit of the “Monica Pretelini 
Saenz Hospital” hospitals in Mexico City and Toluca City 
respectively. The study was conducted according to the 
tenets of the declaration of Helsinki and all sensitive data 
were managed according to the Health insurance Port-
ability and Accountability Act (HIPAA) rules. Due to the 
retrospective nature of the study, informed consents were 
not obtained at this time.
We reviewed all medical records and RetCam-III 
fundus and FA images (Clarity Medical Systems, Pleas-
anton, CA, USA) from two different hospitals. We 
included all files from diagnosed with ROP with a birth 
weight ≥1500  g or gestational age of ≥32  weeks, with 
fluorescein angiography performed. From each file, we 
extracted the gestational age, gender, birth weight, age at 
the first visit and history of supplemental oxygen, along 
with all medical notes regarding fundus description. 
Images files in JPEG format from the fundus examina-
tion and FA were extracted from the RetCam-II hard 
drive. Clinical description of the images and neonate 
assessment was done by a retinal specialist with exten-
sive expertise in ROP (MAMC). Images were later clas-
sified according to the observed vascular abnormalities 
and findings were analyzed for similarities with ROP and 
OIR.
Descriptive statistics was done using an excel spread-
sheet (Excel 2007; Microsoft Corp., Redmond, WA, USA) 
for means, standard deviations and standard error of the 
mean.
Results
From a total of 294 infants diagnosed with ROP, we 
included 28 eyes from 14 patients with peripheral vas-
cular abnormalities who met the inclusion criteria 
described in the “Methods” section. Mean gestational age 
was 33.7 ±  0.7  weeks (range 33–35  weeks); mean birth 
weight was 1848 ± 135 g (range 1650–2100 g) and mean 
age at first visit was 38.7 ±  1.8  weeks of postmenstrual 
age (range 38–43  weeks). Patient’s demographics are 
summarized on Table 1.
Image analysis showed two distinct type of peripheral 
vascular changes:
Group 1 or non-proliferative; the hallmark were exten-
sive areas of capillary non-perfusion along with wide-
spread arteriovenous shunting between adjacent pri-
mary vessels, tortuosity of primary vessels (“plus-like” 
disease), abnormal budding of tertiary vessels and cap-
illaries, abnormal capillary tuffs and absence of foveal 
avascular zone. Vascular changes were readily identi-
fied in FA images (cases 1, 2 and 3).
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Group 2 or proliferative; the hallmark was some or all 
the characteristic of group 1 plus leakage of dye from 
the boundary between perfused and non-perfused ret-
ina and/or optic disc (case 4).
Representative cases
Case #1
Patient with a non-proliferative OIR (group 1) of 
33 weeks of GA and 1650 g of birth weight examined at 
38 weeks of corrected age (Fig. 1a, b).
Case #2
Female neonate of 33  weeks of gestational age at birth, 
birth weight of 1900 g and history of have been exposed 
to high concentration of supplemental oxygen. The 
patient was screened for ROP at 37 weeks of gestational 
age (Fig. 2).
Case #3
Group 1 OIR of a newborn of 33 weeks of gestational age 
and 1905  g at birth examined at 38  weeks of corrected 
age (Fig. 3).
Case #4
Male neonate of 34 weeks of gestational age, birth weight 
of 1870 g and history of have been exposed to high con-
centration supplemental oxygen including tracheal intu-
bation. He had sepsis during hospitalization (Fig. 4).
Table 1 Demographic characteristics of the 14 patients diagnosed with suspected OIR
Patient Gestational age  
at birth (weeks)
Gender Weight at  
birth (g)




1 33 Female 1905 38 Yes
2 34 Male 1950 39 Yes
3 34 Male 1830 40 Yes
4 35 Male 2100 41 Yes
5 33 Female 1670 37 Yes
6 33 Female 1700 36 Yes
7 33 Male 1810 38 Yes
8 33 Female 1900 37 Yes
9 35 Female 1760 43 Yes
10 34 Male 1870 39 Yes
11 34 Male 1990 40 Yes
12 34 Male 2000 38 Yes
13 33 Male 1650 38 Yes
14 34 Female 1740 39 Yes
Fig. 1 Color picture (a) and FA (b) show areas of retinal non‑perfusion with vasoobliteration and arteriovenous shunting within areas of the retina 
that are already vascularized (white dashed line at the limit of vascularized and non vascularized). The borders of this area are irregular, and there are 
no sprouts visible. It is noteworthy that there is absence of foveal avascular zone
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Discussion
Immature retinas are especially susceptible to damage 
during development. When compared to adults, cho-
roidal flow is almost absent and retinal blood flow has a 
narrow flow range that must be strictly auto-regulated. 
Moreover, retinas in neonates are rich in mitochondria; 
capable of producing high amounts of reactive oxy-
gen species, which cannot be counterbalanced by 
antioxidants in utero. Consequently, excessive supple-
mental oxygen, a high fluctuation of oxygen saturation 
in the retina (hypoxia-hyperoxia) and a strictly choroi-
dal blood flow, have a crucial role in the pathogenesis of 
Fig. 2 Fundus examination showed a flat demarcation‑like line in retinal periphery (a). FA images showed areas of capillary non‑perfusion and arte‑
riovenous shunting in what appeared to be mature retinal vessels (b, c). The patient was placed on rigorous monitoring and intensive regulation 
of oxygen. She was reassessed 1 week later (38 weeks). Fundus examination revealed formation of new vessels and patches (“islands”) of leaking 
vessels (d). Twelve weeks later, weekly screening showed that vessels continued growing toward the periphery (e). This patient was classified as 
group 1
Fig. 3 Image a shows an elevated demarcation line. Image b shows microaneurysms or tufts posterior to the ridge along with discrete leakage of 
fluorescein at the ridge (white arrow). There are also vasoobliterative and capillary free areas (circle). Of note is that the demarcation line is irregular 
and we can find capillary free islands posterior to the ridge
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proliferative vascular diseases in premature newborns 
[12–17].
In our country most of the Neonatal Intensive Care 
Units do not count with blenders that allow continuing 
oxygen regulation when hospitalized or discharged for 
parental control of oxygen intake. Consequently, we do 
not have a record that states the level of oxygen received 
at any time during the day over the time-lapse that oxy-
gen is administered. Recently, an important publication 
from our country stated that uncontrolled oxygen sup-
plementation is the major risk for ROP requiring treat-
ment for infants born >32  weeks of GA, and that its 
regulation diminished the frequency of treatment for 
ROP [18]. This is the importance of our paper, that posi-
tions that there are clear angiographic differences among 
those with low-risk for developing ROP from regular risk 
ROP patients; findings that support that there must be a 
different etiology for the development of the retinopathy, 
which is still needed to be confirmed with histology and 
molecular studies.
In middle-income countries, neonatal survival has been 
increasing in later years. Which brings as a consequence, 
an increase in neonatal care-related pathologies, includ-
ing ROP [19]. Standard of care in neonatal intensive care 
units (oxygen not well regulated), surveillance guidelines 
and treatment can vary widely in these countries; which 
leads to increase in ROP-like disease events, even in 
heavier and more mature babies, not typically considered 
at risk for ROP in developed countries. Zepeda-Romero 
et al. reported a case of a newborn of 1280 g birth weight 
who presented arteriovenous shunts capillary loss and 
multiple areas of non-perfusion; similar to the cases 
described herein. In this case series, we describe the 
peripheral vascular abnormalities of 28 eye belonging 
to 14 neonates with no medical history of extreme pre-
maturity or very low birth weight, but who have been 
exposed to unmonitored high concentration of oxygen 
for variable periods of time [20]. All eyes developed vas-
cular abnormalities, similar to those described as typical 
ROP but with distinctive differences like venous beading, 
tortuosity and dilation of major retinal vessels and capil-
laries (“plus-like” disease), arteriovenous shunting, areas 
of capillary closure, abnormal capillary tufts, microaneu-
rysms, patches (“islands”) of leaking vessels. An addi-
tional finding is the absence of avascular foveal zone 
which has been reported by Henaine et al. [21] in 50% of 
patients born at 36 weeks of gestational age or more.
In patients with ROP, newly formed vessels are not fully 
mature, resulting in areas of non-perfusion. Although 
this vascular abnormality is not usually seen in patients 
with more mature retinas, it is a key component of 
murine models of ROP known as OIR [13, 14, 16, 17].
The hallmark of ROP stage 1 is a visible flat demarca-
tion line between vascular and avascular peripheral ret-
ina [22]. In our case series, patients classified as having 
vascular abnormalities belonging to group 1, also had a 
flat demarcation line. But, unlike ROP, a clear capillary-
free area, posterior to the demarcation line, can also 
be observed. This capillary-free zone also shows arte-
riovenous shunting among primary vessels, not typically 
seen in ROP stage 1. Additionally, patients with ROP 
stage 1 show perivascular leakage of dye during FA; a 
characteristic not found in patient classified as group 1 
in this case series. The authors speculate that this phe-
nomenon could be explained because in neonates with 
ROP, the cellular junctions in immature retinal vessels 
are still developing and the vessels are still not fully sup-
ported by pericytes (Fig.  5). Therefore, leakage could 
be observed. On the contrary, neonates in group 1 had 
no clear history of extreme prematurity, which make 
highly probable that they had more developed retinas 
with more mature vessels, already fully supported by 
pericytes which do not allowed leakage. Obliteration of 
previously formed retinal vessels, resulting in extensive 
Fig. 4 Fundus examination showed neovascularization in zone 1 (along temporal vascular arcades), extensive areas of capillary drop‑out, subhya‑
loid and vitreous hemorrhages and macular fibrosis (a, b). FA of right eye shows vascular tortuosity and leakage secondary to neovascularization (c). 
The patient was classified as group 2
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areas of capillary drop-out could also be observed in 
patients from group 1.
Stage 2 ROP is characterized by an elevated ridge at 
the demarcation line which subtly leaks fluorescein at 
the forming ridge. In our series, patients in group 1 who 
presented a ridge, also presented leakage but to a lesser 
degree, possibly indicating more mature vessels. Vascu-
lar abnormalities beyond the posterior limit of the ridge 
are not classically observed in stage 2 ROP [23]. To our 
knowledge, there is only one report of vascular tufts 
posterior to the ridge adjacent to retinal hypoperfusion 
areas. In our series, patients typically shown aneurysm or 
tufts in an “island” pattern within normal-looking retina, 
far posterior to the demarcation line and ridge. Con-
versely to ROP cases, patients within group 1 could also 
show a marked boundary, easily distinguishable between 
vascular and avascular areas of the retina and areas of 
capillary non-perfusion. The demarcation line had a 
“dentate” pattern (deep bays) within an irregular ridge.
In stage 3 ROP, neovascularization appears at the ridge. 
In our series, patients classified as group 2 or prolifera-
tive cases, also had neovascularization at the optic disc. 
This feature is very uncommon in ROP. Finally, the most 
aggressive cases in group 2 also shown a “4-lobe” vascu-
lar topography, similarly to cases with Aggressive poste-
rior retinopathy of prematurity (APROP) [24].
Conclusion
In summary, this case series describes the peripheral 
vascular abnormalities in a group of patient older than 
32  weeks of gestational age, and heavier than 1500  g 
but who developed specific morphological and func-
tional vascular angiographic findings, despite having a 
more mature appearance in their retinal vasculature. The 
good amount of differences with classic ROP on fundus 
examination and FA, makes the authors wonder if there 
are additional pathological process in play besides the 
already described for ROP. At this time, the lack of evi-
dence prevent us to label this vascular abnormalities as 
solely induced by oxygen dysregulation at the neonatal 
intensive care unit (like OIR in the laboratory) or as a dif-
ferent manifestation of ROP within the same spectrum 
of the disease, in heavier and more mature neonates. A 
complete ophthalmological examination (including fun-
dus examination and FA evaluation) is advisable in all 
neonates, even if they are older of 32 weeks of gestational 
age and/or heavier than 1500 g, whenever they have his-
tory of have been exposed to excessive oxygen; in order 
to make precise diagnosis and establish proper treatment 
if needed. More studies are needed in order to identify 
the precise pathologic mechanism and the entire spec-
trum of peripheral vascular abnormalities in neonates 
without strict criteria of prematurity, but that are still 
being exposed to high concentrations of oxygen during 
neonatal care.
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